| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
Jeongshim Lee, Jee Suk Chang, Mi Ryung Roh, Minkyu Jung, Choong-Kun Lee, Byung Ho Oh, Kee Yang Chung, Woong Sub Koom, Sang Joon Shin
Cancer Res Treat. 2020;52(3):730-738.   Published online February 13, 2020    DOI: https://doi.org/10.4143/crt.2019.598
                              Supplementary      
A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models
Jae-Rim Heo, Kyung-A Hwang, Seung U. Kim, Kyung-Chul Choi
Cancer Res Treat. 2019;51(2):797-811.   Published online September 14, 2018    DOI: https://doi.org/10.4143/crt.2018.364
                                 Cited By 3
Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland
Tadeusz Dębniak, Rodney J Scott, Rodney A Lea, Bohdan Górski, Bartłomiej Masojć, Cezary Cybulski, Andrzej Kram, Romuald Maleszka, Tomasz Gromowski, Katarzyna Paszkowska-Szczur, Aniruddh Kashyap, Marcin R. Lener, Karolina Malińska, Emilia Rogoża, Dawid Murawa, Helena Rudnicka, Jakub Deptuła, Jan Lubiński
Cancer Res Treat. 2019;51(1):337-344.   Published online May 14, 2018    DOI: https://doi.org/10.4143/crt.2018.157
                              
Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions
Si-Hyung Lee, Jee Eun Kim, Hong Sun Jang, Kyu Hyun Park, Byung Ho Oh, Sang Joon Shin, Kee Yang Chung, Mi Ryung Roh, Sun Young Rha
Cancer Res Treat. 2018;50(4):1378-1387.   Published online January 22, 2018    DOI: https://doi.org/10.4143/crt.2017.535
                              Supplementary         Cited By 5
Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
Jee Hung Kim, Su-Jin Shin, Soo Jin Heo, Eun-Ah Choe, Chang Gon Kim, Minkyu Jung, Ki Chang Keum, Jin Sook Yoon, Sung Chul Lee, Sang Joon Shin
Cancer Res Treat. 2018;50(4):1238-1251.   Published online December 28, 2017    DOI: https://doi.org/10.4143/crt.2017.534
                              Supplementary         Cited By 2
Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma
Daniel Lorenzo, María Ochoa, Josep Maria Piulats, Cristina Gutiérrez, Luis Arias, Jaume Català, María Grau, Judith Peñafiel, Estefanía Cobos, Pere Garcia-Bru, Marcos Javier Rubio, Noel Padrón-Pérez, Bruno Dias, Joan Pera, Josep Maria Caminal
Cancer Res Treat. 2018;50(4):1130-1139.   Published online December 4, 2017    DOI: https://doi.org/10.4143/crt.2017.171
                                 Cited By 2
Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea
Chang-Mo Oh, Hyunsoon Cho, Young-Joo Won, Hyun-Joo Kong, Yun Ho Roh, Ki-Heon Jeong, Kyu-Won Jung
Cancer Res Treat. 2018;50(3):729-737.   Published online July 14, 2017    DOI: https://doi.org/10.4143/crt.2017.166
                              Supplementary         Cited By 21
Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study
Shu-Hui Wang, Ching-Chi Chi, Zi-Hao Zhao, Tao-Hsin Tung
Cancer Res Treat. 2018;50(2):428-435.   Published online May 10, 2017    DOI: https://doi.org/10.4143/crt.2017.110
                                 Cited By 1
Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea
Tae Wan Kim, Euncheol Choi, Jeonghoon Park, Dong-ho Shin, Su Kyung Jung, Susie Seok, Kwan Ho Cho, Joo-Young Kim, Dae Yong Kim, Tae Hyun Kim, Yang Kwon Suh, Yeon Joo Kim, Sung Ho Moon
Cancer Res Treat. 2018;50(2):335-344.   Published online April 19, 2017    DOI: https://doi.org/10.4143/crt.2017.070
                              
Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients
Yeona Cho, Jee Suk Chang, Jin Sook Yoon, Sung Chul Lee, Yong Bae Kim, Joo Ho Kim, Ki Chang Keum
Cancer Res Treat. 2018;50(1):138-147.   Published online March 24, 2017    DOI: https://doi.org/10.4143/crt.2016.391
                                 Cited By 1
Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
Jae-Hyeon Kim, Jun-Ho Ahn, Michael Lee
Cancer Res Treat. 2017;49(4):947-959.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.280
                              Supplementary         Cited By 22
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
Minkyu Jung, Jeeyun Lee, Tae Min Kim, Dae Ho Lee, Jin Hyung Kang, Sung Young Oh, Soo Jung Lee, Sang Joon Shin
Cancer Res Treat. 2017;49(1):44-53.   Published online April 27, 2016    DOI: https://doi.org/10.4143/crt.2016.024
                                 Cited By 14
PTEN Methylation Dependent Sinonasal Mucosal Melanoma
Sang Hee Lee, Mi Ryung Roh, Beodeul Kang, Kyu Hyun Park, Soo Hee Kim, Sang Eun Lee, Sun Young Rha
Cancer Res Treat. 2016;48(2):853-858.   Published online March 18, 2015    DOI: https://doi.org/10.4143/crt.2014.356
                                 Cited By 1
Preliminary Suggestion about Staging of Anorectal Malignant Melanoma May Be Used to Predict Prognosis
Won Young Chae, Jong Lyul Lee, Dong-Hyung Cho, Chang Sik Yu, Jin Roh, Jin Cheon Kim
Cancer Res Treat. 2016;48(1):240-249.   Published online March 6, 2015    DOI: https://doi.org/10.4143/crt.2014.305
                                 Cited By 4
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin
Cancer Res Treat. 2015;47(4):781-789.   Published online February 16, 2015    DOI: https://doi.org/10.4143/crt.2014.261
                                 Cited By 3
Construction of MAGE - 3 Expressing Plasmid for Development of DNA Vaccine Encoding MAGE - 3 Cancer Antigen
Jong Wook Park, Mi Hyun Lee, Soo Jung Yoon, Won Ki Baek, Seong Il Suh, Min Ho Suh, Kang Dae Lee, Tae Hyun Yu
J Korean Cancer Assoc. 2000;32(1):191-199.
      
Effects of Lipid Soluble Components of Korean Red Ginseng on Proliferation and Cell Cycle Regulation Factors in Human Melanoma Cell Lines
Hye Jeong Kim, Joo Young Roh, Jong Ouck Choi, Sul Hee Park, In Sun Kim, Jeongwon Sohn, Chong Kun Ryu
J Korean Cancer Assoc. 1997;29(6):965-976.
      
A Case of the Pancreatic Pseudocyst due to Metastatic Malignant Melanoma
Bong Soo Chung, Jin Cheon Kim, Chang Sik Yu, Han Il Lee, Chang Nam Kim, Duck Jong Han, Gyeong Hoon Kang
J Korean Cancer Assoc. 1997;29(3):528-533.
      
Malignant Melanoma of the Cecum , Unknown Origin
Jin n Yeo, Nam Il Kim, Jung Soo Kim, Hae Myung Jeon, Seung Jin Yoo, Jae Sung Kim, Eun Jung Lee
J Korean Cancer Assoc. 1995;27(6):1077-1083.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community